These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22778874)

  • 1. Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.
    Koschatzky S; Tschammer N; Gmeiner P
    ACS Chem Neurosci; 2011 Jun; 2(6):308-16. PubMed ID: 22778874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective agonists for dopamine/neurotensin receptor heterodimers.
    Koschatzky S; Gmeiner P
    ChemMedChem; 2012 Mar; 7(3):509-14. PubMed ID: 22213714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
    Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
    Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
    Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
    Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in [
    Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential allosteric modulation within dopamine D
    Plach M; Schäfer T; Borroto-Escuela DO; Weikert D; Gmeiner P; Fuxe K; Friedland K
    Sci Rep; 2019 Nov; 9(1):16312. PubMed ID: 31704949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.
    Fuxe K; Von Euler G; Agnati LF; Merlo Pich E; O'Connor WT; Tanganelli S; Li XM; Tinner B; Cintra A; Carani C
    Ann N Y Acad Sci; 1992; 668():186-204. PubMed ID: 1361113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
    Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell.
    Delle Donne KT; Chan J; Boudin H; Pélaprat D; Rostène W; Pickel VM
    Synapse; 2004 Jun; 52(3):176-87. PubMed ID: 15065218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
    Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
    Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB
    Bagher AM; Laprairie RB; Toguri JT; Kelly MEM; Denovan-Wright EM
    Eur J Pharmacol; 2017 Oct; 813():66-83. PubMed ID: 28734930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and
    Bumbak F; Keen AC; Gunn NJ; Gooley PR; Bathgate RAD; Scott DJ
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1372-1383. PubMed ID: 29596791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a GPCR-ligand pair that simulates the activation of D(2L) by Dopamine.
    Tschammer N; Dörfler M; Hübner H; Gmeiner P
    ACS Chem Neurosci; 2010 Jan; 1(1):25-35. PubMed ID: 22778805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction.
    White JF; Grodnitzky J; Louis JM; Trinh LB; Shiloach J; Gutierrez J; Northup JK; Grisshammer R
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12199-204. PubMed ID: 17620610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
    Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
    Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.